Michael Lobell

1.0k total citations
18 papers, 816 citations indexed

About

Michael Lobell is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Michael Lobell has authored 18 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Hematology and 5 papers in Molecular Biology. Recurrent topics in Michael Lobell's work include Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Cancer Research and Treatments (2 papers). Michael Lobell is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Cancer Research and Treatments (2 papers). Michael Lobell collaborates with scholars based in United States. Michael Lobell's co-authors include Jorge J. Yunis, Richard D. Brunning, Robert B. Howe, Juan J. Yunis, Robert E. Rydell, Martin M. Oken, Mark A. Arnesen, Mary Mayer, Robert Sylvester and R. Curtis Bay and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Michael Lobell

17 papers receiving 757 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Lobell United States 13 531 202 179 178 142 18 816
G V Dahl United States 12 620 1.2× 212 1.0× 568 3.2× 120 0.7× 109 0.8× 15 890
C Bernasconi Italy 16 499 0.9× 149 0.7× 126 0.7× 444 2.5× 113 0.8× 55 905
Gita Massey United States 14 678 1.3× 221 1.1× 308 1.7× 162 0.9× 79 0.6× 40 1.1k
Susumu Inoue United States 14 374 0.7× 181 0.9× 207 1.2× 156 0.9× 87 0.6× 46 695
Nasrollah Hakami United States 14 331 0.6× 292 1.4× 209 1.2× 75 0.4× 71 0.5× 28 880
GK Rivera United States 11 576 1.1× 232 1.1× 794 4.4× 126 0.7× 128 0.9× 11 1.1k
Carl E. Krill United States 14 123 0.2× 202 1.0× 121 0.7× 66 0.4× 121 0.9× 24 612
A. Robert Turner Canada 14 252 0.5× 237 1.2× 94 0.5× 116 0.7× 189 1.3× 33 850
Kazuko Hamamoto Japan 17 788 1.5× 435 2.2× 345 1.9× 133 0.7× 138 1.0× 47 1.2k
JP Marie France 14 436 0.8× 561 2.8× 173 1.0× 226 1.3× 736 5.2× 26 1.4k

Countries citing papers authored by Michael Lobell

Since Specialization
Citations

This map shows the geographic impact of Michael Lobell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lobell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lobell more than expected).

Fields of papers citing papers by Michael Lobell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lobell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lobell. The network helps show where Michael Lobell may publish in the future.

Co-authorship network of co-authors of Michael Lobell

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Lobell. A scholar is included among the top collaborators of Michael Lobell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Lobell. Michael Lobell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mahadevan, Daruka, Kimiko Della Croce, Christopher Riley, et al.. (2006). Transcriptosome and serum cytokine profiling of an atypical case of myelodysplastic syndrome with progression to acute myelogenous leukemia. American Journal of Hematology. 81(10). 779–786. 26 indexed citations
2.
Baker, Laurence H., G. D. Demetri, David S. Mendelson, et al.. (2005). A randomized phase 2 study of the thrombospondin-mimetic peptide ABT-510 in patients with advanced soft tissue sarcoma (STS). Journal of Clinical Oncology. 23(16_suppl). 9013–9013. 14 indexed citations
3.
Garland, Linda L., Cathryn Rankin, Katherine Scott, et al.. (2004). Molecular correlates of the EGFR signaling pathway in association with SWOG S0218: a phase II study of oral EGFR tyrosine kinase inhibitor OSI-774 (NSC-718781) in patients with malignant pleural mesothelioma (MPM). Journal of Clinical Oncology. 22(14_suppl). 3007–3007. 12 indexed citations
4.
Garland, Linda L., Cathryn Rankin, Katherine Scott, et al.. (2004). Molecular correlates of the EGFR signaling pathway in association with SWOG S0218: a phase II study of oral EGFR tyrosine kinase inhibitor OSI-774 (NSC-718781) in patients with malignant pleural mesothelioma (MPM). Journal of Clinical Oncology. 22(14_suppl). 3007–3007. 3 indexed citations
5.
Lobell, Michael, et al.. (1998). Barriers to Cancer Screening in Mexican-American Women. Mayo Clinic Proceedings. 73(4). 301–308. 47 indexed citations
6.
Sylvester, Robert, et al.. (1989). Homoharringtonine-induced hyperglycemia.. Journal of Clinical Oncology. 7(3). 392–395. 5 indexed citations
7.
Yunis, Jorge J., Michael Lobell, Mark A. Arnesen, et al.. (1988). Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. British Journal of Haematology. 68(2). 189–194. 187 indexed citations
8.
Lobell, Michael, et al.. (1988). Lymphocyte aggregation in response to adrenergic stimulation. Blood. 71(5). 1470–1474. 6 indexed citations
9.
Sylvester, Robert, Alan C. Fisher, & Michael Lobell. (1987). Cytarabine-Induced Cerebellar Syndrome: Case Report and Literature Review. Drug Intelligence & Clinical Pharmacy. 21(2). 177–180. 16 indexed citations
10.
Sylvester, Robert, et al.. (1987). Excretion of hydroxyurea into milk. Cancer. 60(9). 2177–2178. 21 indexed citations
11.
Burton, J. D., et al.. (1986). Ibuprofen-Associated Pure White-Cell Aplasia. New England Journal of Medicine. 314(10). 624–625. 33 indexed citations
12.
Yunis, Juan J., et al.. (1986). Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood. 67(6). 1721–1730. 186 indexed citations
13.
Lobell, Michael. (1985). Clinical manifestations of acute leukemia.. PubMed. 68(5). 357–60. 1 indexed citations
14.
Sylvester, Robert, et al.. (1984). Impaired Phenytoin Bioavailability Secondary to Cisplatinum, Vinblastine, and Bleomycin. Therapeutic Drug Monitoring. 6(3). 302–305. 17 indexed citations
15.
Yunis, Jorge J., Richard D. Brunning, Robert B. Howe, & Michael Lobell. (1984). High-Resolution Chromosomes as an Independent Prognostic Indicator in Adult Acute Nonlymphocytic Leukemia. New England Journal of Medicine. 311(13). 812–818. 171 indexed citations
16.
Lobell, Michael, et al.. (1975). Drug induced hemolytic anemia.. PubMed. 58(3). 239–43.
17.
Evans, Roger W., et al.. (1969). Fatal intravascular consumption coagulopathy in meningococcal sepsis. The American Journal of Medicine. 46(6). 910–918. 42 indexed citations
18.
Lobell, Michael. (1966). The Clinical Significance of Fever in Hodgkin's Disease. Archives of Internal Medicine. 117(3). 335–335. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G V Dahl Breakdown of academic impact, for papers by C Bernasconi Breakdown of academic impact, for papers by Gita Massey Breakdown of academic impact, for papers by Susumu Inoue Breakdown of academic impact, for papers by Nasrollah Hakami Breakdown of academic impact, for papers by GK Rivera Breakdown of academic impact, for papers by Carl E. Krill Breakdown of academic impact, for papers by A. Robert Turner Breakdown of academic impact, for papers by Kazuko Hamamoto Breakdown of academic impact, for papers by JP Marie
Rankless by CCL
2026